Lipocine (LPCN) Misses Q3 EPS by 67c

Lipocine (NASDAQ: LPCN) reported Q3 EPS of ($1.27), $0.67 worse than the analyst estimate of ($0.60).

For earnings history and earnings-related data on Lipocine (LPCN) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Roblox announces standalone apps, browser play, and creator wallet
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue